Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
-2.65M
-
Total reported value, excl. options
-
$24.2M
-
Value change
-
-$5.79M
-
Number of buys
-
24
-
Number of sells
-
-17
-
Price
-
$1.61
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q1 2021
53 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2021.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 75.5M outstanding shares and own 19.94% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (4.07M shares), Sio Capital Management, LLC (2.19M shares), VANGUARD GROUP INC (1.64M shares), BOXER CAPITAL, LLC (920K shares), Maven Securities LTD (900K shares), RENAISSANCE TECHNOLOGIES LLC (893K shares), BlackRock Inc. (710K shares), TWO SIGMA INVESTMENTS, LP (663K shares), TWO SIGMA ADVISERS, LP (645K shares), and SILVERARC CAPITAL MANAGEMENT, LLC (606K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.